Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients.

Hiroshi Tsubamoto; Yoshihiro Ito; Riichiro Kanazawa; Ryu Wada; Yoko Hosoda; Okuto Honda; Ryu Takeyama; Riya Sakane; Yu Wakimoto; Hiroaki Shibahara

首页> 外文期刊>The journal of obstetrics and gynaecology research >Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients.

【24h】

Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients.

机译：晚期卵巢癌患者姑息化疗和临终关怀的获益。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Chemotherapy after 1st Ref can be offered and hospice enrollment during the terminal stages is encouraged for recurrent ovarian cancer patients.

机译：对于复发性卵巢癌患者，可以提供1 Ref后的化学疗法，并鼓励晚期患者接受临终关怀。

著录项

来源
《The journal of obstetrics and gynaecology research》 |2014年第5期|共8页
作者
Hiroshi Tsubamoto; Yoshihiro Ito; Riichiro Kanazawa; Ryu Wada; Yoko Hosoda; Okuto Honda; Ryu Takeyama; Riya Sakane; Yu Wakimoto; Hiroaki Shibahara;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献
中文文献
专利

1. Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients. [J] . Hiroshi Tsubamoto, Yoshihiro Ito, Riichiro Kanazawa, The journal of obstetrics and gynaecology research . 2014,第5期

机译：晚期卵巢癌患者姑息化疗和临终关怀的获益。
2. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients [J] . Taylor Jolyn S., Zhang Ning, Rajan Suja S., Gynecologic Oncology: An International Journal . 2019,第3期

机译：我们如何使用临终关怀：临终关怀的招待所和老年卵巢癌患者的成本
3. End-of-Life Preferences, Length-of-Life Conversations, and Hospice Enrollment in Palliative Care: A Direct Observation Cohort Study among People with Advanced Cancer [J] . Robert Gramling, Luke T. Ingersoll, Wendy Anderson, Journal of palliative medicine . 2019,第2期

机译：生活结束偏好，生活长度的谈话和姑息治疗的读入姑息治疗：直接观察群体在具有晚期癌症的人群中的研究
4. Exploring a New Quantitative Image Marker to Assess Benefit of Chemotherapy to Ovarian Cancer Patients [C] . Seyedehnafiseh Mirniaharikandehei, Ornkar Patil, Faranak Aghaei, Medical Imaging 2017 : Imaging Informatics for Healthcare, Research, and Applications . 2017

机译：探索新的定量图像标记物以评估卵巢癌患者化疗的获益
5. Associations between DNA repair SNPs and outcomes to platinum-based chemotherapy in ovarian cancer patients. [D] . Ruszczyk, Melanie Ursula. 2009

机译：卵巢癌患者的DNA修复SNP与铂类化疗的预后之间的关联。
6. Hope Quality of Life and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study [O] . Katrin M. Sjoquist, Michael L. Friedlander, Rachel L. OConnell, 2013

机译：接受铂抗性/难治性复发性卵巢癌化疗的女性的希望生活质量和治疗所带来的益处：妇科癌症群间症状益处研究
7. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients [O] . Jolyn S. Taylor, Ning Zhang, Suja S. Rajan, 2019

机译：我们如何使用临终关怀：临终关怀招待所模式和老年卵巢癌患者的成本
8. Chemotherapy-Induced Cognitive Impairment: A Novel Prospective Study of the Cognitive Effects of Platinum Taxane-Based Chemotherapy in Ovarian Cancer Patients. [R] . Miller, R. 2016

机译：化疗引起的认知障碍：基于紫杉烷的化疗对卵巢癌患者认知影响的新前瞻性研究。

Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients.

摘要

著录项

相似文献

相关主题

期刊订阅